NCT07829250

Brief Summary

Quantify the impact of an online Virtual Community of Practice (VCoP) to increase pharmacist knowledge and accelerate provision of pre-exposure prophylaxis (PrEP) for HIV prevention.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
53mo left

Started Nov 2026

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 18, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2026

Expected
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2030

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2031

Last Updated

September 18, 2026

Status Verified

September 1, 2026

Enrollment Period

4.2 years

First QC Date

September 14, 2026

Last Update Submit

September 14, 2026

Conditions

HIV Prevention

Keywords

PrEPPharmacyHIV prevention

Outcome Measures

Primary Outcomes (1)

  • Time to first PrEP prescription

    Time to first PrEP prescription by participating pharmacists as self-reported.

    for 2 years from participant enrollment.

Secondary Outcomes (3)

  • PrEP Clinics Started

    within 2 years of participant enrollment

  • Total numbers of PrEP prescriptions initiated

    within 2 years of participant enrollment

  • characteristics of PrEP patients

    2 years post-enrollment

Study Arms (2)

Enhanced Standard of Care

ACTIVE COMPARATOR

This arm will be sent a syllabus introducing them to the six-month business and program plan. Assignments will be delivered every other week, focusing on clinical, epidemiological, and business related educational tasks to be completed to prepare pharmacist to offer PrEP. The study team will be available for email assistance.

Behavioral: Enhanced Standard of Care

Virtual Community of Practice Arm

EXPERIMENTAL

VCoP arm participants will have the same assignments as described in the enhanced SoC arm. Additionally, pharmacists and staff randomized to gain VCoP access will be invited by the research coordinator to the VCoP. The VCoP will include the research team and pharmacists with experience in PrEP provision to provide education and peer support.

Behavioral: Virtual Community of Practice

Interventions

Virtual Community of PracticeBEHAVIORAL

Healthcare communities of practice (CoPs) are becoming increasingly popular. CoPs unite individuals with common interests and provide opportunity to collaboratively learn and develop skills to improve professional practice, and reduce isolation. CoPs can play a role when educational needs cannot be satisfied by traditional methods. With advances in technology and the COVID-19 pandemic, virtual communities of practice (VCoPs) have spread across the globe. One of the primary benefits of online VCoPs is expanded potential for professional development and remote networking. VCoP members can use asynchronous communication to develop relationships and learn from peers who have experience with laws, policies, insurance companies and other healthcare institutions across the U.S. This education and peer support provided by VCoPs could be particularly beneficial for pharmacists in rural areas or in EHE jurisdictions without access to similar resources as academic or urban pharmacists.

Virtual Community of Practice Arm
Enhanced Standard of CareBEHAVIORAL

A self-guided business and program planning. This arm will be sent a syllabus introducing them to the six-month business and program plan. Assignments will be delivered every other week, focusing on clinical, epidemiological, and business related educational tasks to be completed to prepare pharmacist to offer PrEP. The study team will be available for email assistance.

Enhanced Standard of Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pharmacists or pharmacy staff working at pharmacy in U.S.
  • Pharmacy is not currently providing PrEP

You may not qualify if:

  • Any potential participants unable to fully complete the proposed study activities due to health or other concerns will be excluded in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Joanne Stekler, MD, MPH

    University of Washington

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lisa Niemann

CONTACT

206-744-8887niemal@uw.edu

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Emeritus: School of Medicine, Allergy & Infectious Diseases

Study Record Dates

First Submitted

September 14, 2026

First Posted

September 18, 2026

Study Start (Estimated)

November 1, 2026

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

February 28, 2031

Last Updated

September 18, 2026

Record last verified: 2026-09